ENTA
Enanta Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.70
-0.71 ▼ -5.29%
🌙 3월 13일 5:51 PM ET (한국 3/14 06:51)
$12.53
-0.17 ▼ -1.34%
| Index | RUT | P/E | - | EPS (ttm) | -3.2 | Insider Own | 5.12% | Shs Outstand | 0.03B | Perf Week | -6.2% |
| Market Cap | 0.37B | Forward P/E | - | EPS next Y | 19.41% | Insider Trans | -0.86% | Shs Float | 0.03B | Perf Month | -10.88% |
| Enterprise Value | 0.38B | PEG | - | EPS next Q | -0.51 | Inst Own | 91.14% | Short Float | 7.94% | Perf Quarter | -11.62% |
| Income | -0.07B | P/S | 5.5 | EPS this Y | 35.67% | Inst Trans | 18.15% | Short Ratio | 8.32 | Perf Half Y | 46.65% |
| Sales | 0.07B | P/B | 2.91 | EPS next 5Y | 17.2% | ROA | -21.1% | Short Interest | 2.19M | Perf YTD | -19.47% |
| Book/sh | 4.36 | P/C | 1.98 | EPS past 3/5Y | 13.4% -16.17% | ROE | -60.01% | 52W High | -25.95% ($17.15) | Perf Year | 85.94% |
| Cash/sh | 6.4 | P/FCF | - | Sales past 3/5Y | -8.82% -11.81% | ROIC | -25.14% | 52W Low | 210.51% ($4.09) | Perf 3Y | -71.82% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 35.29% | Gross Margin | 92.64% | Volatility(W/M) | 5.22% 5.88% | Perf 5Y | -75.67% |
| Dividend TTM | - | EV/Sales | 5.61 | Sales Y/Y TTM | 0.58% | Oper. Margin | -109.08% | ATR (14) | 0.81 | Perf 10Y | -56.95% |
| Dividend Ex-Date | - | Quick Ratio | 4.44 | EPS Q/Q | 60.43% | Profit Margin | -106.8% | RSI (14) | 38.87 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.44 | Sales Q/Q | 9.76% | SMA20 | -9.52% ($14.04) | Beta | 0.98 | Target Price | $18.5 |
| Payout | - | Debt/Eq | 1.53 | Earnings | 2000000 | SMA50 | -6.99% ($13.65) | Rel Volume | 1.8 | Prev Close | $13.41 |
| Employees | 120 | LT Debt/Eq | 1.25 | EPS/Sales Surpr. | 45.29% 17.04% | SMA200 | 17.84% ($10.78) | Avg Volume(3M) | 0.26M | Price | $12.7 |
| IPO | 2013/3/21 | Option/Short | Yes/Yes | Trades | 3212 | Volume | 473,344 | Change | -5.29% |
뉴스 로딩 중...